Sun Pharmaceutical Industries Ltd.

Company Overview

Sun Pharma was founded in 1983 and offers products in over 100 countries. The company’s product portfolio includes branded generics, pure generics, innovative specialty products, and APIs. The company has development and manufacturing capabilities for various dosage forms, including tablets, capsules, ointments, creams, injectables, sprays, liquids, drug delivery systems, active pharmaceutical ingredients (APIs), and intermediates.

The company has expanded through strategic acquisitions, including Ranbaxy Laboratories, strengthening its market position. With a focus on innovation, Sun Pharma invests in research and development to develop complex generics, novel drug delivery systems, and specialty therapies. The company has 43 manufacturing sites located across the globe.

Financial Highlights (FY 2023)

Company's Business Segments

• Revenue from contracts with customers : Revenue from customer contracts is recognized when control of the goods or services is transferred to the customer. Revenue from services rendered is recognized in the profit or loss as the underlying services are performed. This segment also involves developing, Manufacturing, Marketing, and distributing Pharmaceutical products across multiple therapeutic areas.